Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open‐label extension phaseElke Weißhaar, Sonja Ständer, Gil Yosipovitch et al.|Journal of the European Academy of Dermatology and Venereology|2021Cited by 48